Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism

Endocrine Journal

Volumn 58, Issue 1, 2011, Pages 55-58

  Hamada, Noboru ^a   Momotani, Naoko ^b   Ishikawa, Naofumi ^c   Noh, Jaeduk Yoshimura ^c   Okamoto, Yasuyuki ^d   Konishi, Toshiaki ^a   Ito, Koichi ^c   Ito, Kunihiko ^c  

^a Sumire Hospital   (Japan)

^b Tokyo Association of Health Service   (Japan)

^c ITO HOSPITAL   (Japan)

^d Sumire Clinic   (Japan)

Author keywords

Graves' disease; Neonatal hyperthyroidism; Pregnancy; Radioiodine treatment; TSH receptor antibody

Indexed keywords

IODINE 131; THYROTROPIN RECEPTOR ANTIBODY;

ANTIBODY BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; GRAVES DISEASE; HIGH RISK POPULATION; HUMAN; HYPERTHYROIDISM; NEONATAL HYPERTHYROIDISM; NOTE; PREDICTION; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; IMMUNOGLOBULINS, THYROID-STIMULATING; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; IODINE RADIOISOTOPES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RECEPTORS, THYROTROPIN; RETROSPECTIVE STUDIES; RISK;

EID: 79251605567     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K10E-123     Document Type: Note

References (14)

1. McGregor AM, McLachlan SM, Smith BR, Hall R (1979) Effect of irradiation on thyroid-autoantibody production. Lancet 2 (8140): 442-444.
2. Bech K, Nistrup Madsen S (1980) Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease. Clin Endocrinol (Oxf) 13: 417-424.
3. McKenzie MJ, Zakarija M (1992) Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 2: 155-159.
4. Clavel S, Madec AM, Bornet H, Deviller P, Stefanutti A, Orgiazzi J (1990) Anti TSH-receptor antibodies in pregnant patients with autoimmune thyroid disorder. Br J Obstet Gynaecol 97: 1003-1008.
5. Smith CM, Gavranich J, Cotterill A, et al. (2000) Congenital neonatal thyrotoxicosis and previous maternal radioiodine therapy. Brit Med J 320: 1260-1261.
6. Kubota S, Ohye H, Sasaki I, Nishihara E, Kudo T, Fukata S, Amino N, Kuma K, Mitsuda N, Miyauchi A (2005) Successful use of iodine and levothyroxine to treat Graves' disease in a pregnant patient with allergy to antithyroid drugs and high thyrotropin-binding inhibitor immunoglobulin after radioiodine therapy. Thyroid 15: 1373-1376.
7. Kaplan MM, Meier DA, Dworkin HJ (1998) Treatment of hyperthyroidism with radioactive iodine. Endocrinol Metab Clin North Am 27: 205-223.
8. Hamada N, Momotani N, Okamoto Y, Yoshimura H, Ishikawa N, Ito K, Ito K (2000) Radioiodine treatment for Graves' patients who want pregnant in near future. Folia Endocrinologica Japonica 76: 109 (In Japanese).
9. Lafranchi SH, Hanna CE (2005) Graves' disease in the neonatal period and childhood. In: Braverman LE and Utiger RD (ed) The Thyroid Ninth Edition. Lippincott Williams & Wilkins, Philadelphia, 1049-1059.
10. Tajiri J (2005) Neonatal hyperthyroidism in the pregnancy after radioiodine treatment for Graves' disease. Folia Endocrinologica Japonica 81: 112 (In Japanese).
11. Hamada N (2007) Treatment of pregnant patients complicated with Graves' disease. In: Hamada N (ed) Perfect Guide of medical care for thyroid disease. SHINDAN TO CHIRYO SHA, Inc., Tokyo: 83-90 (In Japanese).
12. Teng CS, Yeung RT, Khoo RK, Alagaratnam TT (1980) A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves' disease treated by subtotal thyroidectomy or radioactive iodine. J Clin Endocrinol Metab 50: 1005-1010.
13. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tørring O (2008) TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158: 69-75.
14. Kamijo K (2007) TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves' disease. Endocr J 54: 619-624.